Metabolon Awarded Patent for Metabolomics Software
News Oct 28, 2008
Metabolon, Inc. announced that the company has been awarded a patent for its proprietary metabolomics software, Visual PHIL™, which provides analysis and a unique visual display of metabolomic data. The software enables the analysis of a series of raw and complex data sets being generated from a variety of instruments into one comprehensive visual display that can indicate the presence of the selected metabolites across a group of samples.
“In the past, studies were conducted through analysis of one sample at a time. This technology allows us to see a comprehensive study view—in a visual display—which enables us to more quickly, and with a higher degree of certainty, identify compounds and hone in on biomarkers,” said Michael Milburn, chief scientific officer at Metabolon. “With Metabolon’s technology, we can offer our clients insight into the biochemical and physiological state of a sample to further research in areas like toxicology and cell line development.”
Using the Visual PHIL technology, Metabolon has conducted over 200 commercial studies as well as identified biomarkers associated with a variety of indications which it is using in the commercial development of several diagnostic products.
“We have long recognized Visual PHIL as a must-have technology for metabolomics research and it has served as a critical component to Metabolon’s service and diagnostic offerings,” commented John Ryals, Ph.D., CEO of Metabolon. “This patent is another strong addition to our IP portfolio, further reinforcing the company as the clear market leader in the industry.”
The awarded patent (US Patent 7’433’787), titled “A System, Method, and Computer Program Product Using a Database in a Computing System to Compile and Compare Metabolomic Data Obtained from a Plurality of Samples”, is the latest addition to Metabolon’s extensive IP portfolio consisting of over 80 US and worldwide patents and patent applications, including broad metabolomics methods, data analysis and biomarker patents, as well as focused product patents.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018